DE602004021675D1 - Verfahren zur herstellung von 5-ä(r)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxyethylü-8-hydroxy-(1h)-chinolin-2-on-salzen, die sich als adrenozeptoragonisten eignen - Google Patents
Verfahren zur herstellung von 5-ä(r)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxyethylü-8-hydroxy-(1h)-chinolin-2-on-salzen, die sich als adrenozeptoragonisten eignenInfo
- Publication number
- DE602004021675D1 DE602004021675D1 DE602004021675T DE602004021675T DE602004021675D1 DE 602004021675 D1 DE602004021675 D1 DE 602004021675D1 DE 602004021675 T DE602004021675 T DE 602004021675T DE 602004021675 T DE602004021675 T DE 602004021675T DE 602004021675 D1 DE602004021675 D1 DE 602004021675D1
- Authority
- DE
- Germany
- Prior art keywords
- hydroxyethylu
- adrenozeptoragonists
- chinolin
- indan
- ylamino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- -1 5,6-DIETHYL-INDAN-2-YLAMINO Chemical class 0.000 title 1
- 241000283073 Equus caballus Species 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
- B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
- B01J23/44—Palladium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Materials Engineering (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45094503P | 2003-02-28 | 2003-02-28 | |
| PCT/EP2004/001981 WO2004076422A1 (en) | 2003-02-28 | 2004-02-27 | Process for preparing 5-‘(r)-2-(5,6-diethyl-indian-2-ylamino)-1-hydroxy-ethyl!-8-hydroxy-(1h)-quinolin-2-one salt, useful as an adrenoceptor agonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004021675D1 true DE602004021675D1 (de) | 2009-08-06 |
Family
ID=32927689
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004021675T Expired - Lifetime DE602004021675D1 (de) | 2003-02-28 | 2004-02-27 | Verfahren zur herstellung von 5-ä(r)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxyethylü-8-hydroxy-(1h)-chinolin-2-on-salzen, die sich als adrenozeptoragonisten eignen |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US7534890B2 (de) |
| EP (1) | EP1599450B1 (de) |
| JP (1) | JP4802089B2 (de) |
| KR (1) | KR101076929B1 (de) |
| CN (1) | CN100363349C (de) |
| AR (1) | AR043406A1 (de) |
| AT (1) | ATE434609T1 (de) |
| AU (1) | AU2004215647B2 (de) |
| BR (1) | BRPI0407904B1 (de) |
| CA (1) | CA2517033C (de) |
| CL (1) | CL2004000381A1 (de) |
| CY (1) | CY1109442T1 (de) |
| DE (1) | DE602004021675D1 (de) |
| DK (1) | DK1599450T3 (de) |
| EC (1) | ECSP055977A (de) |
| ES (1) | ES2326974T3 (de) |
| HK (1) | HK1086255A1 (de) |
| IL (1) | IL170138A (de) |
| MX (1) | MXPA05009156A (de) |
| MY (1) | MY142491A (de) |
| NO (1) | NO331985B1 (de) |
| NZ (1) | NZ541727A (de) |
| PE (1) | PE20040956A1 (de) |
| PL (1) | PL213932B1 (de) |
| PT (1) | PT1599450E (de) |
| RU (1) | RU2332405C2 (de) |
| SI (1) | SI1599450T1 (de) |
| TW (1) | TWI324150B (de) |
| WO (1) | WO2004076422A1 (de) |
| ZA (1) | ZA200506060B (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20100399A1 (es) * | 2003-04-02 | 2010-06-01 | Novartis Ag | Procedimiento para preparar oxi-(1h)-quinolin-2-onas 5-(alfa-haloacetil)-8-sustituidas |
| JP4516064B2 (ja) * | 2003-04-04 | 2010-08-04 | ノバルティス アーゲー | 気道疾患の処置のためのキノリン−２−オン誘導体 |
| GB0411056D0 (en) | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
| GB0413960D0 (en) * | 2004-06-22 | 2004-07-28 | Novartis Ag | Organic compounds |
| PL2044025T3 (pl) | 2006-06-30 | 2013-02-28 | Novartis Ag | Pochodne chinolinonu i ich kompozycje farmaceutyczne |
| JP2010520188A (ja) | 2007-02-28 | 2010-06-10 | シプラ・リミテッド | カルモテロールの異性体を調製する方法 |
| US8877930B2 (en) | 2009-11-04 | 2014-11-04 | Massachusetts Institute Of Technology | Continuous flow synthesis of amino alcohols using microreactors |
| WO2011109276A1 (en) | 2010-03-01 | 2011-09-09 | Massachussets Institute Of Technology | Epoxidation catalysts |
| WO2013132514A2 (en) * | 2012-03-09 | 2013-09-12 | Rao Davuluri Ramamohan | A novel process for the preparation of (r)-5-[2-[(5, 6-diethyl-2, 3-dihydro-1h-inden-2-yl) amino]-1-hydroxyethyl]-8-hydroxy quinolin-2(1h)-one |
| WO2014008640A1 (zh) * | 2012-07-11 | 2014-01-16 | 上海威智医药科技有限公司 | 茚达特罗中间体及茚达特罗的合成方法 |
| WO2014008639A1 (zh) * | 2012-07-11 | 2014-01-16 | 上海威智医药科技有限公司 | 制备茚达特罗的方法 |
| EP3848354B1 (de) | 2012-09-21 | 2022-07-27 | Crystal Pharma, S.A.U. | Verfahren zur herstellung von indacaterol und zwischenprodukte davon |
| WO2014044288A1 (en) * | 2012-09-21 | 2014-03-27 | Crystal Pharma Sa | Methods for the preparation of indacaterol and pharmaceutically acceptable salts thereof |
| CZ306252B6 (cs) * | 2013-03-15 | 2016-10-26 | Zentiva, K.S. | Způsob přípravy 5-[(R)-2-(5,6-diethylindan-2-ylamino)-1-hydroxyethyl]-8-hydroxy-(1H)-chinolin-2-onu (indacaterolu) |
| EP3205646A3 (de) | 2013-03-27 | 2017-10-04 | Laboratorios Lesvi, S.L. | Zwischenprodukte zur herstellung von (r)-5-[2-(5,6-diethylindan-2-ylamino)-1-hydroxyethyl]-8-hydroxy-(1h)-chinolin-2-on (indacaterol) |
| ES2815123T3 (es) | 2014-01-09 | 2021-03-29 | Davuluri Ramamohan Rao | Proceso novedoso para la preparación de indacaterol o sus sales aceptables farmacéuticamente |
| US10227305B2 (en) | 2014-08-22 | 2019-03-12 | G. Pratap REDDY | Process for preparing indacaterol and salts thereof |
| CN105693603B (zh) * | 2014-11-24 | 2019-11-29 | 上海医药工业研究院 | 改良的马来酸茚达特罗制备工艺 |
| WO2016161956A1 (zh) * | 2015-04-09 | 2016-10-13 | 正大天晴药业集团股份有限公司 | 茚达特罗或其盐的制备方法 |
| EP3375781A4 (de) * | 2015-07-21 | 2019-01-09 | Sichuan Haisco Pharmaceutical Co., Ltd. | Benzoringderivat mit b2-rezeptoragonisten- und m3-rezeptorantagonisten-aktivitäten und verwendung davon in der medizin |
| EP3347345B1 (de) | 2015-09-29 | 2019-07-31 | Inke, S.A. | Gemischtes solvat von (r)-5-[2-(5,6-diethylindan-2-ylamino)-1-hydroxyethyl]-8-hydroxy-1h-chinolin-2-on-l-tartrat |
| CN107021921A (zh) * | 2016-02-02 | 2017-08-08 | 常州爱诺新睿医药技术有限公司 | 一种茚达特罗中间体的盐及其制备方法 |
| CN107868045A (zh) * | 2016-09-28 | 2018-04-03 | 四川海思科制药有限公司 | 一种茚达特罗中间体的制备方法 |
| CN108101841B (zh) * | 2016-11-24 | 2021-04-06 | 江苏恒瑞医药股份有限公司 | 一种制备茚达特罗或其盐的方法 |
| CN108264483A (zh) * | 2016-12-31 | 2018-07-10 | 天津金耀集团有限公司 | 一种马来酸茚达特罗的制备方法 |
| CN109516974B (zh) * | 2017-09-19 | 2022-05-27 | 南京圣和药业股份有限公司 | 取代嘧啶类pi3k抑制剂的制备方法 |
| EP3735406B1 (de) | 2018-01-02 | 2022-05-11 | Deva Holding Anonim Sirketi | Verfahren zur herstellung von 5-(2-(substituiertem-amino)-1-hydroxyethyl)-8-(substituiertem-oxy)-chinolin-2(1h)-on |
| CN109721534B (zh) * | 2018-09-25 | 2022-05-20 | 四川海思科制药有限公司 | 一种马来酸茚达特罗中间体及其制备方法和用途 |
| CN109988111A (zh) * | 2019-05-06 | 2019-07-09 | 淮北师范大学 | 一种马来酸茚达特罗的杂质及其合成方法 |
| CN110128339B (zh) * | 2019-05-31 | 2022-03-08 | 苏州芝宇生物科技有限公司 | 一种茚达特罗及其盐衍生物的合成方法和合成用中间体 |
| CN113731406B (zh) * | 2021-10-12 | 2023-07-28 | 南京工业大学 | 一种提高钯碳活性加氢脱除保护基的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9405019D0 (en) | 1994-03-15 | 1994-04-27 | Smithkline Beecham Plc | Novel compounds |
| US6541669B1 (en) * | 1998-06-08 | 2003-04-01 | Theravance, Inc. | β2-adrenergic receptor agonists |
| GB9913083D0 (en) * | 1999-06-04 | 1999-08-04 | Novartis Ag | Organic compounds |
-
2004
- 2004-02-25 TW TW093104788A patent/TWI324150B/zh not_active IP Right Cessation
- 2004-02-26 PE PE2004000198A patent/PE20040956A1/es not_active Application Discontinuation
- 2004-02-26 AR ARP040100606A patent/AR043406A1/es not_active Application Discontinuation
- 2004-02-27 SI SI200431222T patent/SI1599450T1/sl unknown
- 2004-02-27 CA CA2517033A patent/CA2517033C/en not_active Expired - Lifetime
- 2004-02-27 EP EP04715306A patent/EP1599450B1/de not_active Expired - Lifetime
- 2004-02-27 ES ES04715306T patent/ES2326974T3/es not_active Expired - Lifetime
- 2004-02-27 MY MYPI20040645A patent/MY142491A/en unknown
- 2004-02-27 RU RU2005129547/04A patent/RU2332405C2/ru active
- 2004-02-27 US US10/546,941 patent/US7534890B2/en active Active
- 2004-02-27 CN CNB2004800054167A patent/CN100363349C/zh not_active Expired - Lifetime
- 2004-02-27 MX MXPA05009156A patent/MXPA05009156A/es active IP Right Grant
- 2004-02-27 CL CL200400381A patent/CL2004000381A1/es unknown
- 2004-02-27 DK DK04715306T patent/DK1599450T3/da active
- 2004-02-27 NZ NZ541727A patent/NZ541727A/en not_active IP Right Cessation
- 2004-02-27 DE DE602004021675T patent/DE602004021675D1/de not_active Expired - Lifetime
- 2004-02-27 PT PT04715306T patent/PT1599450E/pt unknown
- 2004-02-27 PL PL378358A patent/PL213932B1/pl unknown
- 2004-02-27 AU AU2004215647A patent/AU2004215647B2/en not_active Expired
- 2004-02-27 JP JP2006501972A patent/JP4802089B2/ja not_active Expired - Lifetime
- 2004-02-27 AT AT04715306T patent/ATE434609T1/de active
- 2004-02-27 WO PCT/EP2004/001981 patent/WO2004076422A1/en active Application Filing
- 2004-02-27 BR BRPI0407904A patent/BRPI0407904B1/pt not_active IP Right Cessation
-
2005
- 2005-07-28 ZA ZA200506060A patent/ZA200506060B/en unknown
- 2005-08-07 IL IL170138A patent/IL170138A/en active IP Right Grant
- 2005-08-24 EC EC2005005977A patent/ECSP055977A/es unknown
- 2005-08-26 KR KR1020057015981A patent/KR101076929B1/ko active IP Right Grant
- 2005-09-26 NO NO20054452A patent/NO331985B1/no unknown
-
2006
- 2006-05-24 HK HK06105984.1A patent/HK1086255A1/xx not_active IP Right Cessation
-
2009
- 2009-09-24 CY CY20091100993T patent/CY1109442T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004021675D1 (de) | Verfahren zur herstellung von 5-ä(r)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxyethylü-8-hydroxy-(1h)-chinolin-2-on-salzen, die sich als adrenozeptoragonisten eignen | |
| DE502004009768D1 (de) | Verfahren zur herstellung von dreiwertigen organophosphor-verbindungen | |
| DE502004009763D1 (de) | Verfahren zur herstellung von 1-buten | |
| DE602004004663D1 (de) | Verfahren zur herstellung von 2- (chinoxalin-5-ylsulfonylamino) -benzamid-verbindungen | |
| DE60234952D1 (de) | VERFAHREN ZUR HERSTELLUNG VON HEXAHYDROFUROc2,3-BÜFURAN-3-OL | |
| DE502005000428D1 (de) | Verfahren zur Herstellung von 1,2-Diaminocyclohexan-Platin(II)-Komplexen | |
| DE502005001841D1 (de) | Verfahren zur herstellung von 1,4-diphenylazetidinon-derivaten | |
| DE60217096D1 (de) | Verfahren zur herstellung von (s)-(+)- und (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepin-5-carboxamid | |
| DE60302139D1 (de) | Verfahren zur herstellung von aripiprazole | |
| DE602005011814D1 (de) | Verfahren zur herstellung von enantiomerreinen 1,1'-spirobiindan-6,6'-diol-derivaten | |
| DE502005007702D1 (de) | Verfahren zur herstellung von terrylen-3,4:11,12-t | |
| DE602005014280D1 (de) | Verfahren zur herstellung von ä1,4,5ü-oxadiazepinderivaten | |
| DE60202755D1 (de) | Verfahren zur herstellung von imidazolverbindungen | |
| ATE506351T1 (de) | Verfahren zur herstellung von 10,11-dihydro-10- oxo-5h-dibenzoäb,füazepin-5-carboxamid | |
| DE602005026841D1 (de) | Verfahren zur herstellung von 1,2,2,2-tetrafluor-ethyl-difluor-methylether | |
| DE60226310D1 (de) | Verfahren zur herstellung von cycloolefinadditionspolymerisat | |
| ATE296816T1 (de) | Verfahren zur herstellung von ethern, vorzugsweise von thf | |
| ATE328010T1 (de) | Verfahren zur herstellung von polyisobuten | |
| DE502005000950D1 (de) | Verfahren zur herstellung von siloxan-copolymeren | |
| DE60210778D1 (de) | Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen | |
| DE602004004677D1 (de) | Verfahren zur herstellung substituierter 5-amino-pyrazolo-ä4,3-eü-1,2,4-triazoloä1,5-cüpyrimidine | |
| DE60216931D1 (de) | Verfahren zur herstellung von bisphenol-a | |
| DE602004002784D1 (de) | Verfahren zur Herstellung von Polyvinylpyrrolidon-Pulver | |
| DE60335766D1 (de) | Verfahren zur Herstellung von m-Xylylendiamin | |
| DE502004002810D1 (de) | Verfahren zur herstellung von copolymerisaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8328 | Change in the person/name/address of the agent |
Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN |